Cross Site Scripting Vulnerability in SourceCodester Drug Recommendation System
CVE-2026-94016

4.8MEDIUM

Key Information:

Vendor

Sourcecodester
Status
Drug Recommendation System
Vendor
CVE Published:
20 September 2026

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2026-94016?

A security flaw has been identified in the SourceCodester Drug Recommendation System version 1.0, particularly affecting the /drug_recommender/Admin/add_symptom file. The vulnerability arises from improper handling of the 'txtname' argument, allowing attackers to inject malicious scripts, thereby enabling cross site scripting (XSS). This exploit can be executed remotely, potentially affecting users and exposing sensitive information. It is important for users to be aware of this vulnerability and take necessary precautions.

Affected Version(s)

Drug Recommendation System 1.0

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2026-94016 - Proof of Concept

References

https://vuldb.com/vuln/407956
vdb-entrytechnical-description
https://vuldb.com/vuln/407956/cti
signaturepermissions-required
https://vuldb.com/cve/CVE-2026-94016
third-party-advisory

CVSS V4

Score:
4.8
Severity:
MEDIUM
Confidentiality:
None
Integrity:
Low
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
Unknown

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

anubhav106 (VulDB User)
.